Patents by Inventor Bulent Ozpolat

Bulent Ozpolat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR THE TREATMENT OF PKR-ASSOCIATED DISEASES
    Publication number: 20220143030
    Abstract: Provided herein are RNA-dependent protein kinase (PKR)-associated compounds for the treatment of PKR-associated disorders including cancer, neurodegenerative diseases, and inflammatory conditions.
    Type: Application
    Filed: February 7, 2020
    Publication date: May 12, 2022
    Applicant: Board of Regents, The University of Texas System
    Inventors: Apar PATAER, Bulent OZPOLAT, Stephen G. SWISHER, Ruping SHAO
  • Novel Compositions and Methods for Treating Cancer
    Publication number: 20150306077
    Abstract: Provided herein are methods and compositions inter alia for treating diseases, including hyperproliferative diseases, migraine headaches, and depression.
    Type: Application
    Filed: April 28, 2015
    Publication date: October 29, 2015
    Inventors: Bulent Ozpolat, Gabriel Lopez-Berestein, Kevin N. Dalby, Jiney Jose
  • Compositions and methods for treating cancer
    Patent number: 9073851
    Abstract: Provided herein are methods and compositions inter alia for treating diseases, including hyperproliferative diseases, migraine headaches, and depression.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: July 7, 2015
    Assignee: Board of Regents, the University of Texas System
    Inventors: Bulent Ozpolat, Gabriel Lopez-Berestein, Kevin N. Dalby, Jiney Jose
  • Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
    Patent number: 8859727
    Abstract: A nanoparticle-polypeptide complex comprising a bioactive polypeptide in association with a nanoparticle, wherein the bioactive polypeptide is modified by the addition of a chemical moiety that facilitates cellular uptake of the protein. The polypeptide can be a protein or a peptide. In some embodiments, the amino acid sequence of the protein or peptide is derived from the amino acid sequence of a tumor suppressor gene product.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: October 14, 2014
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Jacki Lin, Ralph Arlinghaus, Tong Sun, Lin Ji, Bulent Ozpolat, Gabriel Lopez-Berestein, Jack A. Roth
  • BIOACTIVE FUS1 PEPTIDES AND NANOPARTICLE-POLYPEPTIDE COMPLEXES
    Publication number: 20130266634
    Abstract: A nanoparticle-polypeptide complex comprising a bioactive polypeptide in association with a nanoparticle, wherein the bioactive polypeptide is modified by the addition of a chemical moiety that facilitates cellular uptake of the protein. The polypeptide can be a protein or a peptide. In some embodiments, the amino acid sequence of the protein or peptide is derived from the amino acid sequence of a tumor suppressor gene product.
    Type: Application
    Filed: December 19, 2012
    Publication date: October 10, 2013
    Inventors: Jacki LIN, Ralph ARLINGHAUS, Tong SUN, Lin JI, Bulent OZPOLAT, Gabriel LOPEZ-BERESTEIN, Jack A. ROTH
  • Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
    Patent number: 8338366
    Abstract: A nanoparticle-polypeptide complex comprising a bioactive polypeptide in association with a nanoparticle, wherein the bioactive polypeptide is modified by the addition of a chemical moiety that facilitates cellular uptake of the protein. The polypeptide can be a protein or a peptide. In some embodiments, the amino acid sequence of the protein or peptide is derived from the amino acid sequence of a tumor suppressor gene product.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: December 25, 2012
    Assignee: The Board of Regents of the University of the Texas System
    Inventors: Jacki Lin, Ralph B. Arlinghaus, Tong Sun, Lin Ji, Bulent Ozpolat, Gabriel Lopez-Berestein, Jack A. Roth
  • Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
    Publication number: 20060251726
    Abstract: A nanoparticle-polypeptide complex comprising a bioactive polypeptide in association with a nanoparticle, wherein the bioactive polypeptide is modified by the addition of a chemical moiety that facilitates cellular uptake of the protein. The polypeptide can be a protein or a peptide. In some embodiments, the amino acid sequence of the protein or peptide is derived from the amino acid sequence of a tumor suppressor gene product.
    Type: Application
    Filed: March 14, 2006
    Publication date: November 9, 2006
    Inventors: Jacki Lin, Ralph Arlinghaus, Tong Sun, Lin Ji, Bulent Ozpolat, Gabriel Lopez-Berestein, Jack Roth